| Mrs Chloe Ann Leslie, MA, SLP-CF | |
|
1809 Indian Wells Rd, Alamogordo, NM 88310-4617 | |
| (575) 437-1967 | |
| (575) 437-3969 |
| Full Name | Mrs Chloe Ann Leslie |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1809 Indian Wells Rd, Alamogordo, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548936966 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | CF7451 (New Mexico) | Primary |
| Provider Name | Gallien Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1881768869 PECOS PAC ID: 6103808175 Enrollment ID: O20150921000853 |
News Archive
In Brazil neonatal mortality declined in the 1980's but rates have virtually remained unchanged since the 1990's. Fernando Barros (Hospital de Clinicas, Montevideo, Uruguay) and colleagues studied births in 1992, 1993, and 2004 in the Brazilian city of Pelotas. They found that important changes in maternal characteristics occurred over the 22 years covered by the study.
The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.
It is estimated that around 400 rare diseases have licenced treatments, and a large proportion of these are a consequence of orphan drug legislation, which has helped to incentivise the production of drugs for small patient populations.
Life presents us with choices all the time: salad or pizza for lunch? Tea or coffee afterward? How we make these everyday decisions has been a topic of great interest to economists, who have devised theories about how we assign values to our options and use those values to make decisions.
Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Chloe Ann Leslie, MA, SLP-CF 1809 Indian Wells Rd, Alamogordo, NM 88310-4617 Ph: (575) 437-1967 | Mrs Chloe Ann Leslie, MA, SLP-CF 1809 Indian Wells Rd, Alamogordo, NM 88310-4617 Ph: (575) 437-1967 |
News Archive
In Brazil neonatal mortality declined in the 1980's but rates have virtually remained unchanged since the 1990's. Fernando Barros (Hospital de Clinicas, Montevideo, Uruguay) and colleagues studied births in 1992, 1993, and 2004 in the Brazilian city of Pelotas. They found that important changes in maternal characteristics occurred over the 22 years covered by the study.
The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.
It is estimated that around 400 rare diseases have licenced treatments, and a large proportion of these are a consequence of orphan drug legislation, which has helped to incentivise the production of drugs for small patient populations.
Life presents us with choices all the time: salad or pizza for lunch? Tea or coffee afterward? How we make these everyday decisions has been a topic of great interest to economists, who have devised theories about how we assign values to our options and use those values to make decisions.
Eli Lilly and Company today announced positive top-line results of two additional Phase III AWARD trials for dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes.
› Verified 3 days ago
Adrienne Nicole Herrenbruck, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hawaii Ave, Alamogordo, NM 88310 Phone: 575-812-5977 | |
Ms. Carrie Lopez Balazs, M.ED, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2669 N. Scenic Dr., Gerald Champion Regional Medical Center, Alamogordo, NM 88310 Phone: 575-446-5526 | |
Soraya Cabrera-loeffler, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hawaii Ave, Alamogordo, NM 88310 Phone: 575-812-6000 | |
Margaret Doyle, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Hawaii Ave, Alamogordo, NM 88310 Phone: 575-812-5977 | |
Mrs. Sarah Moralez, MS, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 12th St, Alamogordo, NM 88310 Phone: 575-812-5977 | |
Ms. Emma Grace Lindsey, MA, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2669 Scenic Dr, Alamogordo, NM 88310 Phone: 575-446-5534 | |
Speechbliss Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1461 Columbia Ave, Alamogordo, NM 88310 Phone: 575-404-9152 Fax: 877-311-5440 |